Skip to main content

Table 2 Cox regression analysis for patients treated for IE in Western Norway during 2016–2022a

From: Exploring sex differences in infective endocarditis – a prospective, observational study from Western Norway

Model

Unadjusted

Fully adjusted

Variable

HR

95% CI

p-value

HR

95% CI

p-value

Mitral valve (yes vs. no)

2.64

1.60–4.34

< 0.001

3.01

1.64–5.55

< 0.001

Age (per year)

1.03

1.01–1.05

0.001

1.02

1.00–1.04

0.017

Surgery performed (yes vs. no)

0.28

0.13–0.58

< 0.001

0.39

0.18–0.85

0.018

Female sex (yes vs. no)

1.83

1.11–3.02

0.017

1.37

0.81–2.32

0.241

Aortic valve (yes vs. no)

0.73

0.44–1.21

0.222

1.26

0.68–2.33

0.260

S. aureus (yes vs. no)

1.37

0.82–2.27

0.228

1.53

0.86–2.71

0.147

Enterococci (yes vs. no)

0.82

0.42–1.60

0.552

0.74

0.36–1.54

0.422

Native valve (yes vs. no)

0.85

0.52–1.39

0.523

0.82

0.48–1.39

0.454

  1. HR Hazard ratio, CI Confidence interval, S. aureus Staphylococcus aureus
  2. aAdministrative censoring 90 days censored 432 (87%), events 65 (13%) patients